Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Perrigo Company ( (PRGO) ) is now available.
On July 13, 2025, Perrigo Company entered into an agreement to sell its Dermacosmetics branded business to Kairos Bidco AB for up to €327 million. This transaction, expected to close in the first quarter of 2026, is part of Perrigo’s strategy to streamline its portfolio and focus on high-growth brands, with proceeds directed towards strengthening its balance sheet.
The most recent analyst rating on (PRGO) stock is a Buy with a $38.00 price target. To see the full list of analyst forecasts on Perrigo Company stock, see the PRGO Stock Forecast page.
Spark’s Take on PRGO Stock
According to Spark, TipRanks’ AI Analyst, PRGO is a Neutral.
Perrigo’s overall stock score reflects significant financial challenges, with declining sales and persistent losses weighing heavily. However, the company is making strategic efforts to improve profitability and operational efficiencies, as evidenced by recent earnings call highlights. Technical analysis suggests neutral stock movement, while valuation metrics call for caution due to negative earnings. The dividend yield offers some investor appeal, but risks remain due to macroeconomic uncertainties and cost pressures.
To see Spark’s full report on PRGO stock, click here.
More about Perrigo Company
Perrigo Company plc is a leading provider of consumer self-care products, primarily operating in North America and Europe. The company specializes in over-the-counter self-care solutions that are accessible without a prescription, offering a range of products across various molecules, dosage forms, and value tiers.
Average Trading Volume: 1,187,022
Technical Sentiment Signal: Hold
Current Market Cap: $3.78B
Find detailed analytics on PRGO stock on TipRanks’ Stock Analysis page.